甲基氢化泼尼松

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

甲基氢化泼尼松 基本信息

中文名称:
甲基氢化泼尼松 
中文别名:
6α-甲基泼尼松龙;
11β,17α,21-Trihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione;
甲基泼尼松龙;
11β,17α,21-三羟基-6α-甲基-1,4-孕甾二烯-3,20-二酮;
甲基强的松龙;
甲基氢化泼尼松;
6α-甲基-11β,17α,21-三羟基-1,4-孕甾二烯-3,20-二酮 
英文名称:
Pregna-1,4-diene-3,20-dione,11,17,21-trihydroxy-6-methyl-, (6a,11b)-
英文别名:
6α-methylprednisolone;
6alpha-methylprednisolone;
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;
Methylprednisolone 
CAS No.:
83-43-2
分 子 式:

C22H30O5

分 子 量:
374.48
精确分子量:
374.20900
PSA:
94.83000
MDL:
MFCD00010591
EINECS:
201-476-4
BRN:
2340300
InChI:
InChI=1/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14?,15?,17-,19?,20-,21-,22-/m0/s1
危险品标志:

 

风险术语:

 

安全术语:

S22;S36

分子结构式:
SDS:
查看

甲基氢化泼尼松 制备方法及用途

制备方法

用于生化研究。适用于风湿性关节炎、胶原病、过敏性疾病、眼科疾患、淋巴白血病、软组织炎症及溶血性贫血等。

用途简介

用途

用于生化研究。适用于风湿性关节炎、胶原病、过敏性疾病、眼科疾患、淋巴白血病、软组织炎症及溶血性贫血等。

甲基氢化泼尼松 物化性质

外观与性状:
白色至灰白色结晶粉末
密度:
1.28
熔点:
228-237°C (dec.)
沸点:
571.8ºC at 760 mmHg
闪点:
313.7°C
折射率:
82 ° (C=1, Dioxane)
存储条件/存储方法:

本品应密封干燥保存。

其它信息:

1.      性状:无色结晶

2.      密度(g/mL,25/4℃):不确定

3.      相对蒸汽密度(g/mL,空气=1):不确定

4.      熔点(ºC):228237

5.      沸点(ºC,常压):不确定

6.      沸点(ºC,5.2kPa):不确定

7.      折射率:不确定

8.      闪点(ºC):不确定

9.      比旋光度(º):[α]D20+83°(二氧六环中)。

10.   自燃点或引燃温度(ºC):不确定

11.   蒸气压(kPa,25ºC):不确定

12.   饱和蒸气压(kPa,60ºC):不确定

13.   燃烧热(KJ/mol):不确定

14.   临界温度(ºC):不确定

15.   临界压力(KPa):不确定

16.   油水(辛醇/水)分配系数的对数值:不确定

17.   爆炸上限(%,V/V):不确定

18.   爆炸下限(%,V/V):不确定

19.   溶解性:略微溶于乙醇、二氧六环、甲醇,微溶于丙酮、氯仿,极微溶于乙醚,不溶于水

甲基氢化泼尼松 安全信息

WGK_Germany:
2
德国有关水污染物质的分类清单
危险类别码:
R36/37/38
安全说明:
S22-S36
RTECS号:
TU4146000
安全标志:
S22:不要吸入粉尘。
S36:穿戴合适的防护服装。
危险标志:
Xi

甲基氢化泼尼松 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TU4146000
CHEMICAL NAME :
Pregna-1,4-diene-3,20-dione, 6-alpha-methyl-11-beta-17,21-trihydroxy-
CAS REGISTRY NUMBER :
83-43-2
BEILSTEIN REFERENCE NO. :
2340300
LAST UPDATED :
199701
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C22-H30-O5
MOLECULAR WEIGHT :
374.52
WISWESSER LINE NOTATION :
L E5 B666 OV AHTTT&J A1 CQ E1 FV1Q FQ L1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
2400 ug/kg
TOXIC EFFECTS :
Cardiac - change in rate Lungs, Thorax, or Respiration - respiratory depression Nutritional and Gross Metabolic - body temperature increase
REFERENCE :
BJANAD British Journal of Anesthesia. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1923- Volume(issue)/page/year: 69,422,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
60 mg/kg/3D-I
TOXIC EFFECTS :
Cardiac - pulse rate increase, without fall in BP Vascular - BP lowering not characterized in autonomic section Nutritional and Gross Metabolic - body temperature increase
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year: 99,282,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
20 mg/kg/45M-C
TOXIC EFFECTS :
Cardiac - arrhythmias (including changes in conduction)
REFERENCE :
JRHUA9 Journal of Rheumatology. (920 Yonge St., Suite 608, Toronto, Ont., Canada) V.1- 1974- Volume(issue)/page/year: 13,477,1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,832,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2292 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,832,1982 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
210 mg/kg/6W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes in urine composition Nutritional and Gross Metabolic - weight loss or decreased weight gain Nutritional and Gross Metabolic - changes in sodium
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 1,305,1959 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84067 No. of Facilities: 33 (estimated) No. of Industries: 2 No. of Occupations: 1 No. of Employees: 272 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84067 No. of Facilities: 42 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 2047 (estimated) No. of Female Employees: 983 (estimated)
毒理学数据:

1、急性毒性:

人肠道TDLO:2400ug/kg;人静脉TDLO:60mg/kg/3D-I

人静脉TDLO:20mg/kg/45W-C

大鼠口径LD50:>4mg/kg;

小鼠腹腔LD50:2292mg/kg;

2、其他多剂量毒性:

狗口径TDL0:210mg/kg/6W-I

甲基氢化泼尼松 MSDS

Name: 6-alpha-Methylprednisolone 99% Material Safety Data Sheet
Synonym: Medro
CAS: 83-43-2
Section 1 - Chemical Product   MSDS Name:6-alpha-Methylprednisolone 99% Material Safety Data Sheet
Synonym:Medro

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
83-43-2 6-alpha-Methylprednisolone 99% 201-476-4
Hazard Symbols: XN
Risk Phrases: 40

Section 3 - HAZARDS IDENTIFICATION
  EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed.
Inhalation:
Harmful if inhaled. May cause irritation of the respiratory tract with burning pain in the nose and throat, coughing, wheezing, shortness of breath and pulmonary edema.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
  Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
  General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
  General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
  Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
  Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 83-43-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
 
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 227-231 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C22H30O5
Molecular Weight: 374.207

Section 10 - STABILITY AND REACTIVITY
  Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, carbon dioxide, acid anhydrides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
  RTECS#:
CAS# 83-43-2: TU4146000 LD50/LC50:
CAS# 83-43-2: Oral, rat: LD50 = >4 gm/kg.
Carcinogenicity:
6-alpha-Methylprednisolone - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION
 

Section 13 - DISPOSAL CONSIDERATIONS
  Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION
 
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION
 
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 83-43-2: No information available.
Canada
CAS# 83-43-2 is listed on Canada's NDSL List.
CAS# 83-43-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 83-43-2 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

甲基氢化泼尼松 分子结构与计算化学数据

分子结构数据

1、  摩尔折射率:100.08

2、  摩尔体积(m3/mol):291.4

3、  等张比容(90.2K):804.8

4、  表面张力(dyne/cm):58.1

5、  极化率10-24cm3):39.67

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:3

3.氢键受体数量:5

4.可旋转化学键数量:2

5.互变异构体数量:9

6.拓扑分子极性表面积94.8

7.重原子数量:27

8.表面电荷:0

9.复杂度:754

10.同位素原子数量:0

11.确定原子立构中心数量:8

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>

湖北诺纳科技有限公司

产品介绍:
产品名称:甲基强的松龙 Cas号:83-43-2 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶 价格:1.0元 - 25.0元
联系方式:
联系人:张经理 电话:027-59209883 手机:17386169806

湖北云镁科技有限公司

产品介绍:
产品名称:甲基强的松龙 Cas号:83-43-2 纯度:99% 包装信息:176kg,1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶 价格:1.0元 - 176.0元
联系方式:
联系人:方经理 电话:027-59206672 手机:18327059871

沧州恩科医药科技有限公司

产品介绍:
产品名称:甲基强的松龙 Cas号:83-43-2 纯度:98% 包装信息:1kg,200kg 价格:888.0元 - 999.0元
联系方式:
联系人:赵经理 电话:0317-5106598 手机:13323075105

湖北魏氏化学试剂股份有限公司

产品介绍:
产品名称:甲基氢化泼尼松 Cas号:83-43-2 纯度:>99% 包装信息:25/ 纸板桶 kg 价格:洽谈
联系方式:
联系人:刘涛 电话:027-59101766 手机:13125137661

湖北魏氏化学试剂股份有限公司

产品介绍:
产品名称:甲基氢化泼尼松;甲基泼尼松龙 Cas号:83-43-2 纯度:99% 包装信息:5g,10g,100g,500g,1kg 价格:0.0元 - 1,200.0元
联系方式:
联系人:张经理 电话:027-59102966 手机:18717199209

上海吉至生化科技有限公司

产品介绍:
产品名称:甲基泼尼松龙 Cas号:83-43-2 纯度:98% 包装信息:1gea,5gea 价格:749.0元 - 2,249.0元
联系方式:
联系人:江珊 电话:021-57520831 手机:15316869680

钟祥市耀威生物科技有限公司,

产品介绍:
产品名称:甲基泼尼松龙 Cas号:83-43-2 纯度:99% 包装信息:25kg,25kg,1kg 价格:洽谈
联系方式:
联系人:汪 电话:13260682861 手机:13260682861

广州创丽精细化工制造有限公司

产品介绍:
产品名称:甲基泼尼松龙(6α-甲基泼尼松龙) Cas号:83-43-2 纯度:98% 包装信息:25kg/纸板桶,20kg/纸板桶,1kg/铝箔袋,25kg/牛皮纸袋,25kg/牛皮纸袋 价格:12,000.0元 - 12,000.0元
联系方式:
联系人:李女士 电话:18973039537 手机:18973039537

武汉东康源科技有限公司

产品介绍:
产品名称:甲基强的松龙 Cas号:83-43-2 纯度:99 包装信息:铝箔袋kg,纸板桶kg 价格:洽谈
联系方式:
联系人:王经理 电话:027-81302558 手机:15377521700

黄石永信生物科技有限公司

产品介绍:
产品名称:Methylprednisolone甲泼尼龙杂质 Cas号:83-43-2 纯度:99 包装信息:1 价格:11.0元
联系方式:
联系人:蔡凡 电话:13092790750 手机:13092790750